Note 13 - Earnings (Loss) Per Share - Antidilutive Securities (Details) - shares	3 Months Ended	9 Months Ended
Aug. 28, 2021	Aug. 29, 2020	Aug. 28, 2021	Aug. 29, 2020
Antidilutive securities (in shares)	0	3,500	7,105	93,403
Share-based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	0	0	0	5,250
Unvested Shares [Member]
Antidilutive securities (in shares)	0	3,500	7,105	88,153

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration